A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Electronic Patch to Improve Chronic Wound Monitoring Announced by Graphene Flagship

February 5, 2020

Electronic Patch: Graphene Flagship associated member, Grapheal has developed a pioneering wearable patch for the remote monitoring of chronic wounds.

The flexible and transparent graphene-based biosensor enables doctors and nurses to provide hyper-responsive treatment of chronic wounds. The device will be showcased at Deep Tech EU, at Mobile World Congress 2020, held in Barcelona, Spain on February 24 to 27, 2020.

Evidence suggests effective wound care will become critical for healthcare in Europe as the population ages and the prevalence of chronic wounds increases. The growing frequency of diabetes in Europe is exacerbating the situation, with approximately 5.5 percent of 60 million diabetics in Europe developing a foot wound.

Chronic wounds can take months or even years to heal. In 20 percent of the cases, the injury never heals and can lead to limb amputation. This dramatic consequence is on the rise, with a 19.4 percent increase in limb amputations during 2014-2017 compared to 2010-2013.

At Deep Tech EU, the largest showcase of technologies born out of European Flagships, Grapheal, a spin-off from CNRS-Grenoble (France) will demonstrate how its wound monitoring technology will change the way the healthcare industry deals with the chronic wound epidemic.

Connected to a smartphone, Grapheal’s wearable patch enables continuous monitoring of wounds, to empower caregivers and wound sufferers with a smart and accurate assessment tool. The wound patch measures and stores the bio parameters of the wound and communicates this data to the cloud via a smartphone app. This real-time connectivity ensures nurses and doctors can be alerted to early stages of infection and other complications.

“Our patented formula uses Graphene-on-polymer, in a non-invasive way, to actively react to any changes to the wound”, explained Vincent Bouchiat, Grapheal CEO. “As an atomically thin material, graphene’s electrode conductivity will change according to any physicochemical change, enabling faster detection of problems for patients.”

“Our patch can adapt to any shape of the wound, using Graphene’s thin and flexible properties. In fact, the non-invasive nature of the patch actively stimulates wound healing — and we have led eight preclinical studies to prove its biostimulation properties.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy